We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current 0R3M market cap is 0. The company's latest EPS is EUR and P/E is N/A.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 1,000 | 14k | 6k | 10.76M | 0 |
| Operating Income | -7.64M | -9.67M | -16.01M | -12.8M | -29.11M |
| Net Income | -7.7M | -9.75M | -16.51M | -12.66M | -28.16M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 4.05M | 45.46M | 29.75M | 24.52M | 31.38M |
| Total Liabilities | 2.51M | 2.42M | 3.53M | 7.96M | 4.87M |
| Total Equity | 1.54M | 43.04M | 26.22M | 16.56M | 26.51M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -7M | -11.67M | -14.01M | -11.26M | -21.79M |
| Investing | 459k | -47k | -640k | -28k | -13k |
| Financing | N/A | 49.41M | -90k | -827k | 33.38M |
| Market Cap | 0 |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 0 |
| Average Volume (1 week) | 5k |
| Average Volume (1 Month) | 3.28k |
| 52 Week Change | 0.00% |
| 52 Week High | 4.71 |
| 52 Week Low | 4.71 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Vivoryon Therapeutics Nv |
| Address |
weinbergweg 22 halle 06120 |
| Website | https://www.vivoryon.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
